Influence of cellulose polymers type on in vitro controlled release tablets containing theophylline

Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences

Volumn 43, Issue 4, 2007, Pages 571-579

  Ojoe, Evelyn ^a   Miyauchi, Edna Mitie ^a   Kaneko, Telma Mary ^a   Velasco, Maria Valéria Rolbes ^a   Consiglieri, Vladi Olga ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Controlled release; Ethylcellulose; Hydroxypropylmethyl cellulose; Matrices; Theophylline

Indexed keywords

CALCIUM PHOSPHATE; ETHYL CELLULOSE; HYDROXYPROPYLMETHYLCELLULOSE; LACTOSE; MAGNESIUM STEARATE; POVIDONE; THEOPHYLLINE;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; TABLET COMPRESSION; TABLET FORMULATION;

EID: 42049086983     PISSN: 15169332     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-93322007000400010     Document Type: Article

References (24)

1. BOSWELL-SMITH, V.; CAZZOLA, M.; PAGE, C. P. Are phosphodiesterase 4 inhibitors just more theophylline? J. Allergy Clin. Immunol., v.117, p.1237-1243, 2006.
2. CHAMBIN, O.; CHAMPION, D., DEBRA, Y. C.; ROCHAT-GONTHIER, M. H.; LE MESTE, M.; POURCELOT, Y. Effects of different cellulose derivatives on drug release mechanism studied at a preformulation stage. J. Control. Release, v. 95, p. 101-108, 2004.
3. CHOWDARY, K. P. R.; MOHAPATRA, P.; MURALI KRISHNA, M. N. Evaluation of olibanum and its resin as rate controlling matrix for controlled release of diclofenac. Indian. J. Pharm. Sci., v.68, p.497-500, 2006.
4. COSTA, P.; SOUZA-LOBO, J. M. Formas farmacêuticas de liberação modificada. Rev. Port. Farm., v. 59, p. 181-190, 1999.
5. DÜRIG, T.; VENKATESH, G. M.; FASSIHI, R. An investigation into the erosion behavior of a high drug-load (85%) particulate system designed for an extended-release matrix tablet. Analysis of erosion kinetics in conjunction with variations in lubrication; porosity; and compaction rate. J. Pharm. Pharmacol., v. 51, p. 1085-1092, 1999.
6. FORD, J. L.; RUBINSTEIN, M. H.; HOGAN, J. E. Formulation of sustained release promethazine hydrochloride tablets using hydroxypropylmethylcellulose matrices. Int. J. Pharm., v. 24, p. 327-338, 1985.
7. HUSSAIN, M . S. H.; YORK, P.; TIMMINS, P. Effect of commercial and high purity magnesium stearates on invitro dissolution of paracetamol DC tablets. Int. J. Pharm., v. 78, p. 203-207, 1992.
8. IBRHIM, M. A; DAES, V. H.; BANGUDU, A. B. The contributions of erosion, swelling, and porosity to theophylline release kinetics from Cissus populnea polymer matrices. Drug Dev. Ind. Pharm., v. 26, p. 571-575, 2000.
9. IKEGAMI, K; TAGAWA, K.; OSAWA, T. Bioavailability and in vivo release behavior of controlled-release multiple-unit theophylline dosage forms in beagle dogs, cynomolgus monkeys, and göttingen minipigs. J. Pharm. Sci., v.95, p. 1888-1895, 2006.
10. JALAL, I.; ZMAILY, E.; NAJIB, N. Dissolution kinetics of commercially avilable controlled-release theophylline preparations. Int. J. Pharm., v.52, p.63-70, 1989.
11. LOPES, C. M.; LOBO, J. M. S.; COSTA, P. Formas farmacêuticas de liberação modificada: polímeros hidrofílicos. Rev. Bras. Ciên. Farm., v.41, n.2, p. 143-154, abr./jun., 2005.
12. LORDI, N. Sustained release dosage forms. In: LACHMAN, L., LIEBERMAN, H. A., KANIG, J. L., (Eds.). The theory and practice of industrial pharmacy. Philadelphia: Lea and Febiger, 1986. p.430-478.
13. MANADAS, R.; PINA, M. E.; VEIGA, F. A dissolução in vitro na previsão da absorção oral de fármacos em formas farmacêuticas de liberação modificada. Rev. Bras. Ciên. Farm., v.38, n.4, p. 375-399, 2002.
14. MITCHELL, K.; FORD, J. L.; ARMSTRONG, D. J.; ELLIOT, P. N. C.; HOGAN, J. E.; ROSTRON, C. The influence of substitution type on the performance of methyl cellulose and hydroxypropylmethylcellulose in gels and matrices. Int. J. Pharm., v. 100, p.143-154, 1993.
15. OJOE, E.; MIYAUCHI, E. M.; SAKUDA, T. M.; VELASCO, M. V.; CONSIGLIERI, V. O. Studies on controlled-release of theophylline from matrix tablet formulation. Rev. Bras. Ciênc. Farm., v.39, supl. 3, 2003.
16. PARVEZ, N.; AHMED, T.; MONIF, T.; SAHA, N.; SHARMA, P. L. Comparative bioavailability of three oral formulations of sustained release theophylline in healthy human subjects. Indian J. Pharmacol., v.36, p.29-33, 2004.
17. PATEL, V. F.; PATEL, N. M. Statistical evaluation of influence of viscosity of polymer and types of filler on dipyridamole release from floating matrix tablets. Int. J. Pharm. Sci., v. 69, p. 51-57, 2007.
18. RASLAN, H. K.; MASWADEH, H. In vitro dissolution kinetic study of theophylline from mixed controlled release matrix tablets containing hydroxypropylmethyl cellulose and glycerylbehenate. Indian J. Pharm. Sci., v.68, p.308-312, 2006.
19. REZA, M. S.; QUADIR, M. A.; HAIDER, S. S. Comparative evaluation of plastic, hydrophobic and hydrophyllic polymers as matrices for controlled-release drug delivery. J. Pharm. Pharmaceut. Sci., v.6, p.274-291, 2003.
20. SIEPMANN, J.; PEPPAS, N. A. Modeling of drug release from delivery systems based on hydroxypropylmethylcellulose (HPMC). Adv. Drug Rev., v.48, p.139-157, 2001.
21. SUNG K. C.; NIXON, P. R.; SKOUG, J. W.; JU, T. R.; GAO, P. Effect of formulation variables on drug and polymer release from HPMC-based matrix tablets. Int. J. Pharm., v.142, p.53-60, 1996.
22. TAHARA, K.; YAMAMOTO, K.; NISHIHATA, T. Overall mechanism behind matrix sustained release (SR) tablets prepared with hydroxypropyl methylcellulose 2910. J. Control. Release, v.35, p. 59-66, 1995.
23. UNITED States Pharmacopeia. 30 ed. Rockville: United States Pharmacopeia Convention, 2007. p. 1941-1950.
24. XU, G.; SUNADA, H. Influence of formulation change on drug release kinetics from hydroxypropylmethylcellulose matrix tablets. Chem. Pharm. Bull., v.43, p.483-487, 1995.